Tenax Therapeutics, Inc.
TENX· Nasdaq
TENXTenax Therapeutics, Inc.
Filed Mar 15, 2012 · 10-Q · 44 days after period end · 0001354488-12-001166
| Metric | Q3 2012 | Q3 2011 |
|---|---|---|
| Revenue | $148.26K | $26.59K |
| Net Income | -$7.30M | $2.54M |
| EPS Diluted | -$0.39 | -$0.11 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Tenax Therapeutics, Inc. · CIK 34956 · Engraved from SEC EDGAR
ended Jan 31, 2012 · filed Mar 15, 2012 · 44 d after period end
